Results 101 to 110 of about 3,991 (207)

Enhanced Antiproliferative Activity of Docetaxel by Extremely Low Frequency Electromagnetic Fields in MCF-7 Breast Cancer Cells. [PDF]

Pharmaceutics
Vesal M, Moazen Safaei Y, Ramazi S, Allahverdi A, Abdolmaleki P, Naderi-Manesh H.   +5 more
europepmc   +1 more source

Directly comparing randomized and real-world controls in adjuvant breast cancer. [PDF]

J Comp Eff Res
Walker B, Boyd M, Silver M, Shi J, Bulsara P, Balanchivadze N, Robert NJ.   +6 more
europepmc   +1 more source

Biological fingerprinting analysis of interaction between taxoids in Taxus and microtubule protein by microdialysis coupled, with high-performance liquid chromatography/mass spectrometry for screening antimicrotubule agents

, 2008
Some natural products, such as traditional Chinese medicines(TCMs), contain compounds with anticancer activity and have attracted a great interest in recent years as alternative anticancer therapies.
Kong Liang, Lei Xiao-yuan, Zou Han-fa, Guo Ming, Su Xing-ye   +4 more
core  

Prognostic Significance of the Modified Glasgow Prognostic Score and Systemic Immune-Inflammation Index in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Cabazitaxel. [PDF]

Prostate
Suzuki K, Hirata J, Ueki H, Wakita N, Okamura Y, Bando Y, Hara T, Terakawa T, Hyodo Y, Chiba K, Teishima J, Miyake H.   +11 more
europepmc   +1 more source

Recent advances in the strategic incorporation of fluorine into new-generation taxoid anticancer agents. [PDF]

J Fluor Chem, 2023
Jayanetti K, Takemura K, Bendale H, Garg A, Ojima I.   +4 more
europepmc   +1 more source

Risk Factors and Clinical Significance of Grade ≥3 Neutropenia During the First Cycle of Cabazitaxel Therapy With Primary Pegfilgrastim Prophylaxis in Metastatic Castration-resistant Prostate Cancer. [PDF]

In Vivo
Sato R, Yoshimi Y, Nishio T, Matsunaga YU, Matsumoto R.   +4 more
europepmc   +1 more source

Enhancement of paclitaxel production by Neopestalotiopsis vitis via optimization of growth conditions. [PDF]

PLoS One
Rezazadeh H, Ghanati F, Bonfill M, Nasibi F, Mohammadi Ballakuti N.   +4 more
europepmc   +1 more source

Expression of Survivin and HER-2 as Independent Predictive Factors for Treatment Response in Locally Advanced Breast Cancer: A Prospective Cohort Study. [PDF]

Asian Pac J Cancer Prev
Badiri SW, Indra I, Sampepajung E, Pieter J, Nelwan BJ, Ferianto D, Syamsu SA, Faruk M.   +7 more
europepmc   +1 more source

De-escalated chemotherapy and endocrine therapy outcomes in young women with stage I HR+/HER2+ breast cancer: An international real-world study. [PDF]

Breast
Sella T, van Duijnhoven F, Wildiers H, Venieri C, Pogoda K, Linderholm B, Matos L, Shirron N, De Maio D'Esposito E, Hajjaji N, Matos E, González Cortijo L, Lambertini M, Fortuna A, Rosset L, Constantinidou A, Demasure S, Abu Remilah A, Huygh G, Paluch-Shimon S, Tjan-Heijnen V, Ruyssers N, Gouveia H, Angeli E, Cicin I, Chiappe E, Neven P, Artac M, Kilictas B, Baranseh J, Vicente-Rubio E, Atci M, Shai A.   +32 more
europepmc   +1 more source

Cabazitaxel Demonstrates Potent Antitumour Activity Against Canine Large-Cell Alimentary Lymphoma In Vitro and In Vivo. [PDF]

Vet Comp Oncol
Sakai K, Suzuki N, Furuya M, Ohta H, Kameshima S, Shimamura S.   +5 more
europepmc   +1 more source